Sacituzumab Tirumotecan Plus Anlotinib in Previously Treated ES-SCLC
Clinical trial NCT07388875 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07388875
- Sponsor
- China Medical University, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-24
- Primary completion
- 2027-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.